These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9545802)

  • 1. [Future development of platelet transfusion].
    Tsubaki K
    Rinsho Ketsueki; 1998 Feb; 39(2):78-80. PubMed ID: 9545802
    [No Abstract]   [Full Text] [Related]  

  • 2. The blood components--advancement in haemotherapy.
    Nathan IV; Han P
    J Singapore Paediatr Soc; 1986; 28(3-4):216-26. PubMed ID: 3599928
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood donation in a hospital for transfusion in hematological diseases].
    Ikeda Y
    Rinsho Byori; 1991 Mar; Suppl 88():243-7. PubMed ID: 1856975
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma thrombopoietin concentrations in response to platelet transfusion therapy.
    Möller P; Andersson PO; Andersson AC; Wadenvik H
    Acta Haematol; 2000; 102(3):131-4. PubMed ID: 10692675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Special features of blood transfusions to hematologic patients].
    Oksanen K
    Duodecim; 1998; 114(12):1233-9. PubMed ID: 11524769
    [No Abstract]   [Full Text] [Related]  

  • 6. [Actual conditions and countermeasures for refractory states in platelet transfusion].
    Sezaki T; Hoshijima T; Izumi K
    Rinsho Ketsueki; 1986 Jul; 27(7):1261-4. PubMed ID: 3784006
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transfusion and its adverse effects in patients with hematological disorders].
    Kurata Y
    Rinsho Ketsueki; 2002 Feb; 43(2):76-9. PubMed ID: 11925879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Platelet transfusion for patients with haematological diseases--indications and transfusion triggers].
    Ueda Y
    Rinsho Ketsueki; 2010 Oct; 51(10):1523-30. PubMed ID: 20962486
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood transfusion and cancerology].
    Bosset JF
    Soins; 1981 May; 26(10):31-5. PubMed ID: 7020083
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transfusion therapy in splenectomy in blood diseases].
    Vorob'ev AI; Idel'son LI; Butrov AV; Gorodetskiĭ VM; Abashkin IuA
    Vestn Khir Im I I Grek; 1982 Oct; 129(10):111-7. PubMed ID: 7179654
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemapheresis and hemorheology.
    Avanzi G; Mannini L
    Transfus Sci; 1990; 11(3-4):279-80. PubMed ID: 10149529
    [No Abstract]   [Full Text] [Related]  

  • 12. [Need for thrombocytes among hematologic patients. Medical and economic aspects].
    Richter J
    Lakartidningen; 1993 Apr; 90(14):1390-3. PubMed ID: 8479264
    [No Abstract]   [Full Text] [Related]  

  • 13. [Guide for transfusion of red blood cells, platelets and labile plasma products. Joint directive of the Spanish society of blood transfusion].
    Algora Weber M; Fernández Montoya A; Gómez Villagrán JL; Martín Vega C; Prats Arrojo I; Puig Alcaraz N; Pujol Bosch M; Vesga Carasa MA
    Med Clin (Barc); 1999 Oct; 113(12):471-4. PubMed ID: 10570517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Novel therapeutic strategy for hematological diseases using iPS cell-banking].
    Eto K
    Rinsho Ketsueki; 2012 Jul; 53(7):658-63. PubMed ID: 22975766
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet transfusion and adverse outcomes.
    Vamvakas EC
    Lancet; 2004 Nov 13-19; 364(9447):1736-8. PubMed ID: 15541433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recommendations for platelet transfusion by the Joint Thrombocyte Working Party of the German Societies of Transfusion Medicine and Immunohaematology (DGTI), Thrombosis and Haemostasis Research (GTH), and Haematology and Oncology (DGHO)].
    Greinacher A; Kiefel V; Klüter H; Kroll H; Pötzsch B; Riess H; ; ;
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2675-9. PubMed ID: 17109279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neocytapheresis].
    Varlamova SV
    Gematol Transfuziol; 1990 Jan; 35(1):31-5. PubMed ID: 2184086
    [No Abstract]   [Full Text] [Related]  

  • 18. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates?
    Atoyebi W; Mundy N; Croxton T; Littlewood TJ; Murphy MF
    Br J Haematol; 2000 Dec; 111(3):980-3. PubMed ID: 11122163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion: future directions.
    Slichter SJ
    Vox Sang; 2004 Jul; 87 Suppl 2():47-51. PubMed ID: 15209878
    [No Abstract]   [Full Text] [Related]  

  • 20. Type I CD36 deficiency in hematologic disorder.
    Aota Y; Sumi M; Iguchi T; Okabe S; Gotoh A; Ohyashiki K
    Haematologica; 2004 Aug; 89(8):EIM17. PubMed ID: 15339698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.